SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas will join the panel, "The Research, Funding and Product Continuum" at the Southeast Venture Philanthropy Summit.
News | 03. 20. 2013
Art Pappas will join the panel, "The Research, Funding and Product Continuum" at the Southeast Venture Philanthropy Summit.
